Prognostic significance of diabetes mellitus in patients with atrial fibrillation
Semaglutide is the active ingredient in three medications: Ozempic, Wegovy, and Rybelsus
During semaglutide therapy, patients with a history of diabetic retinopathy should be closely monitored
Possible side effects include: Nausea, diarrhea, vomiting, constipation, mild to moderate abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, belching, hypoglycemia, flatulence, gastroenteritis, loss of lean muscle mass and gastroesophageal reflux disease
Many factors can make pills harder to swallow, from mouth size to bad experiences with swallowing medication in the past